Debiopharm Innovation Fund Investors

Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.

Zip: NA
Funding Status: N/A
Headquarters: Lausanne, Vaud, Switzerland
Founded Date: 2012-01-01
Investor Type: Venture Capital
Investment Stage: Late Stage Venture, Venture
Employee Number: 1-10
Number Of Exists: 6
Acquisitions Number: NA
Estimated Revenue: $4.7M.
Investors Number: 24
Industry: Imaging